Stanley Cohen

  • Vanderbilt University

    The lasting impact of Vanderbilt’s life sciences Nobelists

    As one of the top 50 U.S. universities with the most Nobel Prize winners, Vanderbilt stands as a cornerstone of scientific achievement and ground-breaking research. Read More

    Mar. 7, 2024

  • Vanderbilt University

    A Nobel-worthy discovery spawns a new field—and new therapies

    Cohen was awarded the 1986 Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor, a protein produced in the body that influences the development of nerve and skin tissues by stimulating cell growth and differentiation. The discovery of EGF launched an entire field of research into growth factor signaling and had major impacts on human health. Read More

    Mar. 7, 2024

  • Vanderbilt University

    Researchers discover key step to kidney fibrosis

    Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. Their discovery, reported Nov. 14 in the journal Nature Communications,… Read More

    Nov. 22, 2023

  • Cohen Innovation Fund Awards Announced Supporting Two High-Risk, High-Reward Projects

    Cohen Innovation Fund Awards Announced Supporting Two High-Risk, High-Reward Projects

    By Aaron Conley Stanley Cohen and Vanderbilt Chancellor Joe Wyatt (1986). Houra Merrikh, professor of biochemistry, and Teru Nakagawa, associate professor of molecular physiology and biophysics, have both been selected to receive one-year research awards from the Stanley Cohen Innovation Fund. The awards will support groundbreaking and… Read More

    Sep. 28, 2021